PMID- 24532332 OWN - NLM STAT- MEDLINE DCOM- 20160509 LR - 20201216 IS - 1522-726X (Electronic) IS - 1522-1946 (Linking) VI - 83 IP - 4 DP - 2014 Mar 1 TI - Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease. PG - 649-54 LID - 10.1002/ccd.25233 [doi] AB - OBJECTIVES: To assess the safety and effectiveness of performing percutaneous coronary intervention (PCI) before transcatheter aortic valve implantation (TAVI). BACKGROUND: The presence of coronary artery disease (CAD) negatively impact procedural outcomes and long-term survival after (TAVI). The management of obstructive CAD before TAVI is not yet well established. METHODS: Patients with severe symptomatic aortic stenosis (AS) (n = 249) that underwent TAVI were divided into two groups: patients with CAD (subdivided to patients treated with TAVI alone and to patients that underwent PCI before TAVI) and patients with isolated AS. Procedural endpoints, device success and adverse events were considered according to the Valve Academic Research Consortium (VARC) definitions. RESULTS: Of a cohort of 249 consecutive patients with mean age of 83.2 +/- 5.5 years, 83 patients with AS + CAD were treated with TAVI alone, 61 patients with AS + CAD underwent PCI before TAVI and 105 patients underwent TAVI for isolated AS. The mean duration of follow-up was 17 months (range: 6-36 months). Despite a significantly higher logistic EuroScore of the AS+CAD group compared to the AS alone group (30.1 vs. 21.1 P < 0. 001), the overall VARC-adjudicated endpoints did not differ between the groups. All-cause mortality at 30-days was 1.6% for patients with AS+CAD treated with PCI compared to 2.9% for patients with AS alone (P = 1). CONCLUSIONS: Performing PCI before TAVI in high-risk elderly patients with significant CAD and severe AS is feasible and safe. This combined treatment approach did not increase the periprocedural risk for complications or the all-cause mortality. CI - Copyright (c) 2013 Wiley Periodicals, Inc. FAU - Abramowitz, Yigal AU - Abramowitz Y AD - Department of Cardiology, The Tel-Aviv Medical Center, Tel-Aviv, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. FAU - Banai, Shmuel AU - Banai S FAU - Katz, Guy AU - Katz G FAU - Steinvil, Arie AU - Steinvil A FAU - Arbel, Yaron AU - Arbel Y FAU - Havakuk, Ofer AU - Havakuk O FAU - Halkin, Amir AU - Halkin A FAU - Ben-Gal, Yanai AU - Ben-Gal Y FAU - Keren, Gad AU - Keren G FAU - Finkelstein, Ariel AU - Finkelstein A LA - eng PT - Comparative Study PT - Journal Article DEP - 20131031 PL - United States TA - Catheter Cardiovasc Interv JT - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions JID - 100884139 SB - IM MH - Age Factors MH - Aged MH - Aged, 80 and over MH - Aortic Valve Stenosis/complications/diagnosis/mortality/*therapy MH - *Cardiac Catheterization/adverse effects/mortality MH - Coronary Artery Disease/complications/diagnosis/mortality/*therapy MH - Feasibility Studies MH - Female MH - Heart Valve Prosthesis Implantation/adverse effects/*methods/mortality MH - Humans MH - Kaplan-Meier Estimate MH - Male MH - *Percutaneous Coronary Intervention/adverse effects/mortality MH - Registries MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Severity of Illness Index MH - Time Factors MH - Treatment Outcome OTO - NOTNLM OT - aortic stenosis OT - percutaneous coronary intervention OT - transcatheter aortic valve implantation EDAT- 2014/02/18 06:00 MHDA- 2016/05/10 06:00 CRDT- 2014/02/18 06:00 PHST- 2013/06/09 00:00 [received] PHST- 2013/09/03 00:00 [revised] PHST- 2013/09/29 00:00 [accepted] PHST- 2014/02/18 06:00 [entrez] PHST- 2014/02/18 06:00 [pubmed] PHST- 2016/05/10 06:00 [medline] AID - 10.1002/ccd.25233 [doi] PST - ppublish SO - Catheter Cardiovasc Interv. 2014 Mar 1;83(4):649-54. doi: 10.1002/ccd.25233. Epub 2013 Oct 31.